期刊文献+

经尿道1470 nm激光切除术与TURis治疗非肌层浸润性膀胱癌的疗效比较 被引量:4

Comparison on Efficacy of Transurethral 1470 nm Laser Resection and TURis in the Treatment of Non-Muscle Invasive Bladder Cancer
下载PDF
导出
摘要 目的对比经尿道1 470 nm激光切除术与经尿道双极等离子电切术(TURis)治疗非肌层浸润性膀胱癌(NMIBC的应用价值。方法回顾性分析2016年7月至2018年6月我院156例NMIBC患者的临床资料,根据治疗术式分为激光组(n=74,经尿道1 470 nm激光切除术)和TURis组(n=82, TURis)。观察两组的手术情况、并发症情况及复发情况。结果激光组的手术时间、出血量、住院时间及并发症发生率均优于TURis组(P <0.05)。两组的术后复发率比较差异无统计学意义(P>0.05)。结论与TURis相比,经尿道1 470 nm激光切除术治疗NMIBC在改善手术情况、降低并发症发生率等方面更具优势。 Objective To compare the application value of transurethral 1 470 nm laser resection and transurethral resection in saline(TURis) in the treatment of non-muscle invasive bladder cancer(NMIBC). Methods The clinical data of 156 NMIBC patients in our hospital from July 2016 to June 2018 were retrospectively analyzed. They were divided into laser group(n = 74, transurethral 1 470 nm laser resection) and TURis group(n = 82, TURis) according to the treatment methods. The operation conditions, complications and recurrence of the two groups were observed. Results The operation time, blood loss, hospitalization time and incidence of complications of the laser group were better than those of the TURis group(P <0.05). No statistical difference was found in the postoperative recurrence rate between the two groups(P >0.05). Conclusions Compared with TURis, transurethral 1 470 nm laser resection in the treatment of NMIBC is more advantageous in improving the operation conditions and reducing the incidence of complications.
作者 谭健秋 黄秋宝 冯能贵 许华强 程伟文 陈光耀 陈咏佳 TAN Jianqiu;HUANG Qiubao;FENG Nenggui;XU Huaqiang;CHENG Weiwen;CHEN Guangyao;CHEN Yongjia(Department of Urology, Yangjiang People's Hospital, Yangjiang 529500, China)
出处 《临床医学工程》 2019年第7期881-882,共2页 Clinical Medicine & Engineering
关键词 经尿道1470nm激光切除术 经尿道双极等离子电切术 非肌层浸润性膀胱癌 并发症 复发 Transurethral 1 470 nm laser resection Transurethral resection in saline(TURis) Non-muscle invasive bladder cancer(NMIBC) Complications Recurrence
  • 相关文献

参考文献7

二级参考文献55

  • 1刘萃龙,周茂军,赵豫波,欧阳昀,关维民,吴意光,徐衍盛.1470nm半导体激光汽化术治疗良性前列腺增生症[J].微创泌尿外科杂志,2014,3(2):112-114. 被引量:18
  • 2Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014 [J]. CACancerJClin, 2014, 64(1): 9-29.
  • 3Lenis A T, Chamie K. Bladder cancer in 2014: From the genomic frontier to immunotherapeutics[J]. Nat Rev Urol, 2015, 12(2): 74-76.
  • 4Chamie K, Litwin M S, Bassett J C, et al. Recurrence of high-risk bladder cancer: a population-based analysis [J]. Cancer, 2013, 119(17): 3219-3227.
  • 5Chamie K, Ballon-Landa E, Bassett J C, et al. Quality of diagnostic staging in patients with bladder cancer: a process-outcomes link[J]. Cancer, 2015, 121(3) : 379 -385.
  • 6Engilbertsson H, Aaltonen K E, Bj6rnsson S, et al. Transurethral bladder tumor resection can cause see- ding of cancer cells into the bloodstreamJ. J Urol, 2015, 193(1): 53-57.
  • 7Geavlete B, Multescu R, Georgescu D, et al. Narrow band imaging cystoscopy and bipolar plasma vaporiza- tion for large nonmuscle-invasive bladder tumors-re- sults of a prospective, randomized comparison to the standard approach[J]. Urology, 2012, 79(4): 846- 851.
  • 8He D, Fan J, Wu K, et al. Novel green-light KTP la- ser en bloc enucleation for nonmuscle-invasive bladder cancer: technique and initial clinical experience[J]. J Endourol, 2014, 28(8): 975-979.
  • 9Kramer M W, Wolters M, Cash H, et al. Current evi- dence of transurethral Ho: YAG and Tm: YAG treat- ment of bladder cancer., update 2014 [J]. World J Urol, 2015, 33(4): 571-579.
  • 10Dwivedi U S, Kumar A, Das S K, et al. Relook TURBT in superficial bladder cancer: its importance and its correlation with the tumor ploidy[J]. Urol On- col, 2009, 27(5): 514-519.

共引文献101

同被引文献40

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部